State of Alaska Department of Revenue’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $658K | Buy |
27,561
+1,977
| +8% | +$47.2K | 0.01% | 1256 |
|
|
2025
Q1 | $635K | Sell |
25,584
-583
| -2% | -$14.5K | 0.01% | 1255 |
|
|
2024
Q4 | $492K | Sell |
26,167
-156
| -0.6% | -$2.93K | 0.01% | 1391 |
|
|
2024
Q3 | $396K | Sell |
26,323
-1,005
| -4% | -$15.1K | ﹤0.01% | 1483 |
|
|
2024
Q2 | $781K | Sell |
27,328
-962
| -3% | -$27.5K | 0.01% | 1145 |
|
|
2024
Q1 | $826K | Sell |
28,290
-279
| -1% | -$8.15K | 0.01% | 1135 |
|
|
2023
Q4 | $963K | Sell |
28,569
-348
| -1% | -$11.7K | 0.01% | 1024 |
|
|
2023
Q3 | $887K | Sell |
28,917
-1,343
| -4% | -$41.2K | 0.01% | 1009 |
|
|
2023
Q2 | $1.21M | Sell |
30,260
-1,159
| -4% | -$46.4K | 0.01% | 879 |
|
|
2023
Q1 | $1.28M | Sell |
31,419
-521
| -2% | -$21.3K | 0.02% | 851 |
|
|
2022
Q4 | $1.23M | Buy |
31,940
+215
| +0.7% | +$8.3K | 0.02% | 851 |
|
|
2022
Q3 | $1.69M | Sell |
31,725
-2,637
| -8% | -$140K | 0.02% | 686 |
|
|
2022
Q2 | $2M | Buy |
34,362
+3,290
| +11% | +$192K | 0.02% | 643 |
|
|
2022
Q1 | $2.37M | Sell |
31,072
-470
| -1% | -$35.9K | 0.03% | 603 |
|
|
2021
Q4 | $1.9M | Sell |
31,542
-885
| -3% | -$53.2K | 0.02% | 741 |
|
|
2021
Q3 | $1.82M | Buy |
32,427
+1,965
| +6% | +$110K | 0.02% | 759 |
|
|
2021
Q2 | $1.85M | Buy |
30,462
+772
| +3% | +$46.8K | 0.02% | 736 |
|
|
2021
Q1 | $2.08M | Sell |
29,690
-4,120
| -12% | -$289K | 0.02% | 644 |
|
|
2020
Q4 | $2.02M | Sell |
33,810
-5,927
| -15% | -$355K | 0.02% | 606 |
|
|
2020
Q3 | $2.39M | Buy |
39,737
+10
| +0% | +$601 | 0.03% | 492 |
|
|
2020
Q2 | $2.08M | Buy |
39,727
+3,010
| +8% | +$158K | 0.03% | 565 |
|
|
2020
Q1 | $1.23M | Buy |
36,717
+5,205
| +17% | +$175K | 0.02% | 675 |
|
|
2019
Q4 | $1.43M | Buy |
31,512
+812
| +3% | +$36.8K | 0.02% | 714 |
|
|
2019
Q3 | $1.17M | Buy |
+30,700
| New | +$1.17M | 0.02% | 774 |
|